167 related articles for article (PubMed ID: 34792871)
1. How Interpersonal Psychotherapy Changes the Brain: A Study of fMRI in Borderline Personality Disorder.
Bozzatello P; Morese R; Valentini MC; Rocca P; Bellino S
J Clin Psychiatry; 2021 Nov; 83(1):. PubMed ID: 34792871
[No Abstract] [Full Text] [Related]
2. Group interpersonal psychotherapy (IPT-G) for borderline personality disorder: A randomized controlled study.
Bozzatello P; Blua C; Marin G; Rocca P; Bellino S
J Psychiatr Res; 2023 Dec; 168():157-164. PubMed ID: 37913742
[TBL] [Abstract][Full Text] [Related]
3. Interpersonal Psychotherapy as a Single Treatment for Borderline Personality Disorder: A Pilot Randomized-Controlled Study.
Bozzatello P; Bellino S
Front Psychiatry; 2020; 11():578910. PubMed ID: 33061926
[TBL] [Abstract][Full Text] [Related]
4. Adaptation of interpersonal psychotherapy to borderline personality disorder: a comparison of combined therapy and single pharmacotherapy.
Bellino S; Rinaldi C; Bogetto F
Can J Psychiatry; 2010 Feb; 55(2):74-81. PubMed ID: 20181302
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
Bozzatello P; Rocca P; Uscinska M; Bellino S
CNS Drugs; 2017 Sep; 31(9):809-819. PubMed ID: 28741044
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy with interpersonal psychotherapy adapted for borderline personality disorder: A two-years follow-up.
Bozzatello P; Bellino S
Psychiatry Res; 2016 Jun; 240():151-156. PubMed ID: 27107668
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment of borderline personality disorder with interpersonal psychotherapy and pharmacotherapy: predictors of response.
Bellino S; Bozzatello P; Bogetto F
Psychiatry Res; 2015 Mar; 226(1):284-8. PubMed ID: 25677397
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.
Bellino S; Paradiso E; Bogetto F
J Clin Psychiatry; 2006 Jul; 67(7):1042-6. PubMed ID: 16889446
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.
Bellino S; Paradiso E; Bogetto F
Psychiatry Res; 2008 Nov; 161(2):206-12. PubMed ID: 18848360
[TBL] [Abstract][Full Text] [Related]
10. Mentalization-based treatment in groups for adolescents with borderline personality disorder (BPD) or subthreshold BPD versus treatment as usual (M-GAB): study protocol for a randomized controlled trial.
Beck E; Bo S; Gondan M; Poulsen S; Pedersen L; Pedersen J; Simonsen E
Trials; 2016 Jul; 17(1):314. PubMed ID: 27405522
[TBL] [Abstract][Full Text] [Related]
11. Effect of 3 Forms of Early Intervention for Young People With Borderline Personality Disorder: The MOBY Randomized Clinical Trial.
Chanen AM; Betts JK; Jackson H; Cotton SM; Gleeson J; Davey CG; Thompson K; Perera S; Rayner V; Andrewes H; McCutcheon L
JAMA Psychiatry; 2022 Feb; 79(2):109-119. PubMed ID: 34910093
[TBL] [Abstract][Full Text] [Related]
12. Neural correlates of distraction in borderline personality disorder before and after dialectical behavior therapy.
Winter D; Niedtfeld I; Schmitt R; Bohus M; Schmahl C; Herpertz SC
Eur Arch Psychiatry Clin Neurosci; 2017 Feb; 267(1):51-62. PubMed ID: 27091455
[TBL] [Abstract][Full Text] [Related]
13. Network analysis of functional brain connectivity in borderline personality disorder using resting-state fMRI.
Xu T; Cullen KR; Mueller B; Schreiner MW; Lim KO; Schulz SC; Parhi KK
Neuroimage Clin; 2016; 11():302-315. PubMed ID: 26977400
[TBL] [Abstract][Full Text] [Related]
14. A resting-state fMRI study in borderline personality disorder combining amplitude of low frequency fluctuation, regional homogeneity and seed based functional connectivity.
Lei X; Zhong M; Liu Y; Jin X; Zhou Q; Xi C; Tan C; Zhu X; Yao S; Yi J
J Affect Disord; 2017 Aug; 218():299-305. PubMed ID: 28478359
[TBL] [Abstract][Full Text] [Related]
15. Clinical improvement in patients with borderline personality disorder after treatment with repetitive transcranial magnetic stimulation: preliminary results.
Reyes-López J; Ricardo-Garcell J; Armas-Castañeda G; García-Anaya M; Arango-De Montis I; González-Olvera JJ; Pellicer F
Braz J Psychiatry; 2018; 40(1):97-104. PubMed ID: 28614492
[TBL] [Abstract][Full Text] [Related]
16. Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial.
Magni LR; Carcione A; Ferrari C; Semerari A; Riccardi I; Nicolo' G; Lanfredi M; Pedrini L; Cotelli M; Bocchio L; Pievani M; Gasparotti R; Rossi R;
BMC Psychiatry; 2019 Jun; 19(1):195. PubMed ID: 31234864
[TBL] [Abstract][Full Text] [Related]
17. Classical conditioning in borderline personality disorder: an fMRI study.
Krause-Utz A; Keibel-Mauchnik J; Ebner-Priemer U; Bohus M; Schmahl C
Eur Arch Psychiatry Clin Neurosci; 2016 Jun; 266(4):291-305. PubMed ID: 25814470
[TBL] [Abstract][Full Text] [Related]
18. Oxcarbazepine in the treatment of borderline personality disorder: a pilot study.
Bellino S; Paradiso E; Bogetto F
J Clin Psychiatry; 2005 Sep; 66(9):1111-5. PubMed ID: 16187767
[TBL] [Abstract][Full Text] [Related]
19. Metacognitive interpersonal therapy in borderline personality disorder: Clinical and neuroimaging outcomes from the CLIMAMITHE study-A randomized clinical trial.
Rossi R; Corbo D; Magni LR; Pievani M; Nicolò G; Semerari A; Quattrini G; Riccardi I; Colle L; Conti L; Gasparotti R; Macis A; Ferrari C; Carcione A;
Personal Disord; 2023 Jul; 14(4):452-466. PubMed ID: 37227866
[TBL] [Abstract][Full Text] [Related]
20. Structural brain abnormalities in borderline personality disorder correlate with clinical severity and predict psychotherapy response.
Sampedro F; Farrés CCI; Soler J; Elices M; Schmidt C; Corripio I; Domínguez-Clavé E; Pomarol-Clotet E; Salvador R; Pascual JC
Brain Imaging Behav; 2021 Oct; 15(5):2502-2512. PubMed ID: 33634348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
